Skip to main content
. 2022 Mar 30;78(4):383–393. doi: 10.1136/thoraxjnl-2021-217526

Table 1.

Patient characteristics

Control Sepsis
N 53 53
PRMT4, mean (SD, ng/mL) 7.8 (11.0) 18.4 (28.6)
Demographics
 Age (years), mean (SD) 55 (15.0) 55 (17.5)
 Male, n (%) 31 (58.5) 24 (45.3)
 BMI, mean (SD) 28.8 (9.1) 30.9 (9.4)
Comorbidities, n (%)
 Diabetes 16 (30.2) 22 (41.5)
 COPD 6 (11.3) 11 (20.7)
 Immunosuppression 9 (17) 9 (17)
 Chronic cardiac failure 3 (5.7) 7 (13.2)
 Chronic kidney disease 6 (11.3) 5 (9.4)
 Pulmonary fibrosis 0 (0) 2 (3.8)
 Active neoplasm 3 (5.7) 3 (5.7)
 Chronic liver disease 9 (17) 6 (11.3)
 Alcohol use 13 (24.5) 8 (15.1)
Severity of Illness
 SOFA score,1 mean (SD) 5.2 (2.4) 7.4 (2.6)
 PaO2:FiO2 ratio, mean (SD) 224 (152) 196 (88)
 Shock, n (%) 10 (18.9) 34 (64.2)
 Acute kidney injury, n (%) 22 (41.5) 40 (75.5)
 ICU LOS (days), mean (SD) 8.5 (9.4) 13.4 (9.8)
 30-day mortality, n (%) 6 (11.3) 12 (22.6)
 90-day mortality, n (%) 7 (13.2) 13 (24.5)

BMI, body mass index; FiO2, fraction of inspired oxygen; ICU, intensive care unit; LOS, length of stay; PaO2, arterial partial pressure of oxygen; PRMT4, protein Aarginine N-methyltransferase 4; SOFA, sequential organ failure assessment.